The neutralizing epitope ELDKWA on HIV-1 gp41: Genetic variability and antigenicity

被引:6
作者
Dong, XN [1 ]
Wu, Y [1 ]
Chen, YH [1 ]
机构
[1] Tsinghua Univ, Dept Biol, Immunol Lab, Sch Life Sci Engn, Beijing 100084, Peoples R China
关键词
HIV-1; ELDKWA; genetic variability; subtype; multi-epitope-vaccine;
D O I
10.1016/j.imlet.2005.04.014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Viral evasion through mutations of neutralizing epitopes is a major challenge to AIDS vaccine development and clinical therapy. In this study, we analyzed the genetic variability of principal neutralizing epitope ELDKWA among 5393 HIV isolates in the HIV sequence database (http://www.hiv.lanl.gov). It has been found that six out of seven frequent variants were able to cause the invalidation of famous neutralizing MAb 2F5. Moreover, escape mutations K665S and K665E, often observed in C-subtype and O-group strains, respectively, were reported more frequently in recent years. Furthermore, we studied the antigenicity of these variants. Polyclonal antibodies induced by a candidate multi-epitope-vaccine were able to react with the recombinant gp41, respectively, carrying these variants, indicating that "epitope cocktail" strategy is necessary and helpful in vaccine design. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:81 / 86
页数:6
相关论文
共 23 条
[1]   A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1 [J].
Armbruster, C ;
Stiegler, GM ;
Vcelar, BA ;
Jäger, W ;
Michael, NL ;
Vetter, N ;
Katinger, HWD .
AIDS, 2002, 16 (02) :227-233
[2]   Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection [J].
Baba, TW ;
Liska, V ;
Hofmann-Lehmann, R ;
Vlasak, J ;
Xu, WD ;
Ayehunie, S ;
Cavacini, LA ;
Posner, MR ;
Katinger, H ;
Stiegler, G ;
Bernacky, BJ ;
Rizvi, TA ;
Schmidt, R ;
Hill, LR ;
Keeling, ME ;
Lu, YC ;
Wright, JE ;
Chou, TC ;
Ruprecht, RM .
NATURE MEDICINE, 2000, 6 (02) :200-206
[3]   GENERATION OF HUMAN MONOCLONAL-ANTIBODIES AGAINST HIV-1 PROTEINS - ELECTROFUSION AND EPSTEIN-BARR-VIRUS TRANSFORMATION FOR PERIPHERAL-BLOOD LYMPHOCYTE IMMORTALIZATION [J].
BUCHACHER, A ;
PREDL, R ;
STRUTZENBERGER, K ;
STEINFELLNER, W ;
TRKOLA, A ;
PURTSCHER, M ;
GRUBER, G ;
TAUER, C ;
STEINDL, F ;
JUNGBAUER, A ;
KATINGER, H .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) :359-369
[4]   NEUTRALIZATION OF DIVERGENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS AND PRIMARY ISOLATES BY IAM-41-2F5, AN ANTI-GP41 HUMAN MONOCLONAL-ANTIBODY [J].
CONLEY, AJ ;
KESSLER, JA ;
BOOTS, LJ ;
TUNG, JS ;
ARNOLD, BA ;
KELLER, PM ;
SHAW, AR ;
EMINI, EA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :3348-3352
[5]   Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus [J].
Eckhart, L ;
Raffelsberger, W ;
Ferko, B ;
Klima, A ;
Purtscher, M ;
Katinger, H ;
Ruker, F .
JOURNAL OF GENERAL VIROLOGY, 1996, 77 :2001-2008
[6]   Construction of recombinant targeting immunogens incorporating an HIV-1 neutralizing epitope into sites of differing conformational constraint [J].
Ho, J ;
MacDonald, KS ;
Barber, BH .
VACCINE, 2002, 20 (7-8) :1169-1180
[7]   SITE-DIRECTED MUTAGENESIS BY OVERLAP EXTENSION USING THE POLYMERASE CHAIN-REACTION [J].
HO, SN ;
HUNT, HD ;
HORTON, RM ;
PULLEN, JK ;
PEASE, LR .
GENE, 1989, 77 (01) :51-59
[8]   Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge [J].
Hofmann-Lehmann, R ;
Vlasak, J ;
Rasmussen, RA ;
Smith, BA ;
Baba, TW ;
Liska, V ;
Ferrantelli, F ;
Montefiori, DC ;
McClure, HM ;
Anderson, DC ;
Bernacky, BJ ;
Rizvi, TA ;
Schmidt, R ;
Hill, LR ;
Keeling, ME ;
Katinger, H ;
Stiegler, G ;
Cavacini, LA ;
Posner, MR ;
Chou, TC ;
Andersen, J ;
Ruprecht, RM .
JOURNAL OF VIROLOGY, 2001, 75 (16) :7470-7480
[9]   Anti-idiotypic antibody Ab2/3H6 mimics the epitope of the neutralizing anti-HIV-1 monoclonal antibody 2F5 [J].
Kunert, RE ;
Weik, R ;
Ferko, B ;
Stiegler, G ;
Katinger, H .
AIDS, 2002, 16 (04) :667-668
[10]   Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope protein [J].
Liang, XP ;
Munshi, S ;
Shendure, J ;
Mark, G ;
Davies, ME ;
Freed, DC ;
Montefiori, DC ;
Shiver, JW .
VACCINE, 1999, 17 (22) :2862-2872